3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Squamous Cell Carcinoma of Head and Neck
4
Brain Neoplasms
4
Glioma
3
Glioblastoma
3
Carcinoma, Hepatocellular
3
Neoplasms
2
Head and Neck Neoplasms
2
Skin Neoplasms
1
Sarcoma
1
Neoplasm Metastasis
1
Meningioma
1
Melanoma
1
Liver Cirrhosis
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Astrocytoma
1
Interventions
Temozolomide
61
Radiotherapy
25
Bevacizumab
21
Magnetic Resonance Spectroscopy
20
Irinotecan
18
Filgrastim
15
Carboplatin
15
Carmustine
11
Surgical Procedures, Operative
10
Etoposide
9
antineoplaston AS 2-1
8
antineoplaston A10
8
Specimen Handling
8
sargramostim
7
Radiation
7
Peripheral Blood Stem Cell Transplantation
7
Everolimus
7
Biopsy
7
Vincristine
6
Radiotherapy, Intensity-Modulated
6
Procarbazine
6
O(6)-benzylguanine
6
Erlotinib Hydrochloride
6
Topotecan
5
Melphalan
5
Magnetic Resonance Imaging
5
Lomustine
5
Genetic Therapy
5
Cyclophosphamide
5
Aminolevulinic Acid
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Astrocytoma
×
fluoromisonidazole
×
Clear all
NCT01868906
2018-08-24
FMISOPETSCS
Dr. Negrin University Hospital
Phase 2
Terminated
6 enrolled